FDA Launches Nationwide Effort To Expand Scientific Expertise And Consumer Voices To Advisory Committees

TL;DR

Before you orderOffer from Amazon

Get health and wellness essentials delivered free with Prime

• Fast, free delivery on millions of items
• Prime Video, Amazon Music and more included
• Member-only deals all year

Start your free Prime trial →Free trial for eligible customers · Cancel anytime

As an affiliate, we earn on qualifying purchases.Hide

The FDA announced a nationwide recruitment effort for scientific, technical and professional voting members, as well as consumer representatives, on its advisory committees. Nominations are accepted on a continuing basis, but the agency set November 15 and November 30, 2026, deadlines for first consideration for current and near-term vacancies.

The U.S. Food and Drug Administration on September 30 announced a nationwide effort to recruit scientific experts and consumer representatives for its advisory committees, which provide independent recommendations on issues involving FDA-regulated products. The agency says it is seeking nominations for committees with current or anticipated vacancies, with November deadlines for candidates who want first consideration for near-term openings.

The effort is set out in two Federal Register notices. One seeks qualified scientific, technical and professional voting members across committees with current or expected vacancies. The other seeks consumer representatives, including individuals and consumer organizations, to bring public perspectives into committee discussions. The FDA said nominations will be considered on a continuing basis.

Scientific and technical nominees are expected to have relevant subject-matter expertise, be able to interpret complex information, understand the public-health significance of committee issues and provide objective advice. Consumer representative nominees should have demonstrated involvement with consumer or community-based organizations and be able to assess technical data, discuss benefits and risks, and evaluate product safety and efficacy from a public perspective.

The agency is seeking expertise across multiple fields, including oncology, cardiovascular medicine, neurology, genetics and medical devices. Candidates can apply through the centralized FDA Advisory Committee Membership Nomination portal, and self-nominations are accepted. Members may be invited to serve terms of up to four years.

Who Shapes FDA Advisory Advice

Advisory committees offer the FDA outside expertise and scrutiny as it considers evidence about drugs, vaccines, biologics, medical devices and other regulated products. Their recommendations can inform agency deliberations, though the FDA describes them as advice rather than a replacement for the agency’s own decisions. The recruitment drive concerns who participates in those discussions and which professional and public perspectives are represented.

For consumers, the inclusion of community voices is relevant because committee reviews can weigh potential benefits and risks that affect patients and the wider public. The FDA says consumer representatives are expected to engage with technical material and assess product safety and efficacy from a public perspective. The announcement does not specify how many seats are open or how membership might change as a result of the nominations.

The agency’s stated aim is to widen and strengthen participation. That is the FDA’s characterization of the effort; the release does not provide measures for evaluating whether the recruitment results in a broader range of members or perspectives.

How the Nomination Process Works

FDA advisory committees bring together specialists such as physicians, researchers and biostatisticians, along with patient advocates and consumer representatives. They review evidence on products under FDA oversight and provide independent recommendations intended to inform regulatory deliberations. The September 30 announcement describes recruitment across committees with existing or expected near-term vacancies, rather than the creation of new committees.

For first consideration for current and near-term openings, nominations for consumer representative positions are due by November 15, 2026. Nominations for scientific, technical, professional and other voting-member positions are due by November 30, 2026. The FDA says submissions received after those dates will be considered as later vacancies arise, so the deadlines do not mark the end of the overall nomination process.

The notices and the nomination portal are the agency’s formal routes for applicants. The release says members may serve for terms of up to four years but does not describe the length of every appointment or provide a schedule for filling each opening.

“FDA advisory committees bring together leading scientific minds to engage with the most difficult questions in public health.”

— Kyle Diamantas, acting FDA commissioner of food and drugs

Vacancy Numbers and Selection Details

The FDA release does not state how many positions are available, identify each committee with an opening or say when specific appointments will be made. It refers to current and anticipated near-term vacancies across multiple committees, but does not give a committee-by-committee timetable.

The agency also has not described how many nominations it expects, how it will compare candidates beyond the stated qualifications, or how it will measure whether the effort broadens the perspectives represented. The announcement does not say that nominees will be appointed automatically; it invites nominations for agency consideration.

The two notices set separate first-consideration deadlines for consumer and voting-member positions. The FDA says later submissions will be considered as vacancies arise, but the release does not specify when applicants who miss the November dates might hear back.

November Nomination Deadlines

Prospective nominees can submit materials through the FDA’s centralized membership application portal. Consumer representative nominations submitted by November 15, 2026, and scientific, technical, professional and other voting-member nominations submitted by November 30, 2026, will receive first consideration for current and near-term vacancies, according to the agency.

The FDA says it will continue accepting nominations after those dates for consideration as later openings arise. Its announcement does not give a date for publishing selections or a timetable for filling individual seats, so further updates from the agency will be needed to establish the results of the recruitment effort.

Key Questions

What did the FDA announce?

The FDA announced a nationwide call for nominations to fill current and anticipated advisory committee vacancies. It is seeking scientific, technical and professional voting members, as well as consumer representatives.

What are the nomination deadlines?

For first consideration for current and near-term vacancies, consumer representative nominations are due by November 15, 2026. Scientific, technical, professional and other voting-member nominations are due by November 30, 2026.

Can people nominate themselves?

Yes. The FDA says self-nominations are accepted. Candidates are directed to use the agency’s centralized advisory committee membership nomination portal.

What qualifications does the FDA seek?

Scientific and technical candidates should have relevant expertise, be able to interpret complex information and provide objective advice. Consumer nominees should have involvement with consumer or community organizations and be able to engage with technical data and product risks and benefits.

How long can committee members serve?

The FDA says members are invited to serve for terms of up to four years. The announcement does not provide appointment dates for individual vacancies.

Source: primary